Skip to content

Clinical application of a novel multidimensional integrated analysis technique of fetal free nucleic acid in noninvasive prenatal screening

Clinical application of a novel multidimensional integrated analysis technique of fetal free nucleic acid in noninvasive prenatal screening

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045739
Enrollment
Unknown
Registered
2021-04-23
Start date
2021-04-08
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple chromosomal aneuploidies, microdeletion and microduplication syndromes, and monogenic disorders

Interventions

Case series:None

Sponsors

The Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Adult pregnant woman (aged >=20 years); 2.Gestational age >=12+0 weeks; 3.Singleton pregnancy; 4.Agree to participate in the clinical trial and accept at least one molecular diagnosis (such as prenatal diagnosis, flow product or cord blood diagnosis); 5.High-risk pregnancies requiring prenatal diagnosis include the following: (1)Prenatal ultrasound revealed structural abnormalities; (2)High risk by routine NIPS; (3)Serological prenatal screening suggests high risk; (4)The clinician considers the application of other suspected genetic diseases (e.g., unexplained recurrent abortion, etc.).

Exclusion criteria

Exclusion criteria: 1.Chromosomal abnormality in either of the couple; 2.Received allogeneic blood transfusion, transplantation and allogeneic cell therapy within one year; 3.There is a family history of genetic diseases or a high risk of genetic diseases in the fetus; 4.Complicated with malignant tumor during pregnancy; 5.Other conditions that the clinician considers to significantly affect the accuracy of the results.

Design outcomes

Primary

MeasureTime frame
gene sequencing;karyotype analysis;prenatal ultrasonography;chromosome chip;chromosome copy number variation testing;

Countries

China

Contacts

Public ContactHuang Hefeng

The Obstetrics and Gynecology Hospital of Fudan University

huanghefg@hotmail.com+86 18086614690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026